Robanus-Maandag E - Search Results

1

In vivo analysis of Frat1 deficiency suggests compensatory activity of Frat3.

Jonkers J, van Amerongen R, van der Valk M, Robanus-Maandag E, Molenaar M, Destrée O, Berns A. Jonkers J, et al. Mech Dev. 1999 Nov;88(2):183-94. doi: 10.1016/s0925-4773(99)00187-2. Mech Dev. 1999. PMID: 10534617 Free article.

2

Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene.

van der Lugt NM, Domen J, Linders K, van Roon M, Robanus-Maandag E, te Riele H, van der Valk M, Deschamps J, Sofroniew M, van Lohuizen M, et al. van der Lugt NM, et al. Genes Dev. 1994 Apr 1;8(7):757-69. doi: 10.1101/gad.8.7.757. Genes Dev. 1994. PMID: 7926765 Free article.

3

p107 is a suppressor of retinoblastoma development in pRb-deficient mice.

Robanus-Maandag E, Dekker M, van der Valk M, Carrozza ML, Jeanny JC, Dannenberg JH, Berns A, te Riele H. Robanus-Maandag E, et al. Genes Dev. 1998 Jun 1;12(11):1599-609. doi: 10.1101/gad.12.11.1599. Genes Dev. 1998. PMID: 9620848 Free PMC article.

4

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs.

Schinkel AH, Smit JJ, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CA, van der Valk MA, Robanus-Maandag EC, te Riele HP, et al. Schinkel AH, et al. Cell. 1994 May 20;77(4):491-502. doi: 10.1016/0092-8674(94)90212-7. Cell. 1994. PMID: 7910522

5

Synergy of Nf2 and p53 mutations in development of malignant tumours of neural crest origin.

Robanus-Maandag E, Giovannini M, van der Valk M, Niwa-Kawakita M, Abramowski V, Antonescu C, Thomas G, Berns A. Robanus-Maandag E, et al. Oncogene. 2004 Aug 26;23(39):6541-7. doi: 10.1038/sj.onc.1207858. Oncogene. 2004. PMID: 15221010

6

Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2.

Giovannini M, Robanus-Maandag E, van der Valk M, Niwa-Kawakita M, Abramowski V, Goutebroze L, Woodruff JM, Berns A, Thomas G. Giovannini M, et al. Genes Dev. 2000 Jul 1;14(13):1617-30. Genes Dev. 2000. PMID: 10887156 Free PMC article.

7

Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein.

Giovannini M, Robanus-Maandag E, Niwa-Kawakita M, van der Valk M, Woodruff JM, Goutebroze L, Mérel P, Berns A, Thomas G. Giovannini M, et al. Genes Dev. 1999 Apr 15;13(8):978-86. doi: 10.1101/gad.13.8.978. Genes Dev. 1999. PMID: 10215625 Free PMC article.

8

Adenomatous polyposis coli-mediated control of beta-catenin is essential for both chondrogenic and osteogenic differentiation of skeletal precursors.

Miclea RL, Karperien M, Bosch CA, van der Horst G, van der Valk MA, Kobayashi T, Kronenberg HM, Rawadi G, Akçakaya P, Löwik CW, Fodde R, Wit JM, Robanus-Maandag EC. Miclea RL, et al. BMC Dev Biol. 2009 Apr 8;9:26. doi: 10.1186/1471-213X-9-26. BMC Dev Biol. 2009. PMID: 19356224 Free PMC article.

9

Generation of AKR mink cell focus-forming virus: nucleotide sequence of the 3' end of a somatically acquired AKR-MCF.

Quint W, Boelens W, van Wezenbeek P, Robanus Maandag E, Berns A. Quint W, et al. Virology. 1984 Jul 30;136(2):425-34. doi: 10.1016/0042-6822(84)90178-8. Virology. 1984. PMID: 6087552

10

The primary structure of the putative oncogene pim-1 shows extensive homology with protein kinases.

Selten G, Cuypers HT, Boelens W, Robanus-Maandag E, Verbeek J, Domen J, van Beveren C, Berns A. Selten G, et al. Cell. 1986 Aug 15;46(4):603-11. doi: 10.1016/0092-8674(86)90886-x. Cell. 1986. PMID: 3015420

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters